Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Cardinal Dolan and Dr. Drew Champion New Hope in Addiction Treatment as Fentanyl Crisis Intensifies


News provided by

Neurology News

Oct 23, 2024, 10:00 ET

Share this article

Share toX

Share this article

Share toX

“This Book Will Save Your Life” by Dr. Russell Surasky (Double Board-Certified Neurologist)—Available for pre-order now.
“This Book Will Save Your Life” by Dr. Russell Surasky (Double Board-Certified Neurologist)—Available for pre-order now.

The book you're holding in your hands contains the answers that can save your life, the life of a loved one, or—if you're a doctor—the life of your patient. In the time it takes to read this paragraph, another person will have died from opioid addiction. Everyone is now just one degree of separation from this deadly scourge—either you are suffering, or someone close to you is. Fentanyl, the deadliest of all opioids, has infiltrated every town in America. Recent medical discoveries in neuroscience have proven that addiction is a neurological brain condition that hijacks critical brain circuits, not a psychological problem or moral failure. With this new information, we have developed breakthrough medical treatments that can heal the brain from addiction—and finally unchain those suffering from this deadly affliction. In This Book Will Save Your Life, Dr. Russell Surasky clearly explains these precise new life-saving treatments and how you or your loved one can access them immediately. Active opioid addiction is a medical emergency that—without treatment—is virtually always fatal. The information in this book could save your life and the lives of those you love, forever.

NEW YORK, Oct. 23, 2024 /PRNewswire-PRWeb/ -- Celebrity physician Dr. Drew Pinsky describes neurologist Dr. Russell Surasky's new book as the "last hope for survival," urging, "Don't wait until it's too late" to read this lifesaving message. Cardinal Timothy Dolan calls it an "urgent challenge" for those suffering from addiction and offers their loved ones "hope for a culture of recovery."

Soon to be Released, This Book Will Save Your Life: The New Medical Cure for Opioid Addiction is a "How-to Guide" to surviving the opioid epidemic. It's a must-read for anyone concerned about the hundreds of thousands who die each year from accidental overdose. If you or someone you love is suffering from this debilitating disease, this book is for you.

The lifesaving information in this book could be your last hope for survival—and for those you cherish. Don't wait until it's too late." – Dr. Drew Pinsky, Celebrity Internist and Addiction Medicine Specialist

Post this

Dr. Surasky—a neurologist and board-certified addiction medicine specialist—explains in clear, accessible language how addiction takes hold of the brain and traps individuals in life-and-death struggles. He outlines groundbreaking treatments for opioid and alcohol addiction that are available now.

"Using advanced brain imaging techniques like functional MRIs and PET scans, neurologists can now precisely identify the circuits involved in addiction," says Dr. Surasky. "Addiction is not a matter of morality or willpower—it's a neurological condition. After as little as a few weeks of use, opiates 'hijack' the brain to the point that it needs the drug for survival, and the compulsion to keep using becomes overwhelming. Without reversing these neurological changes, cravings can persist for a lifetime."

Dr. Surasky's work introduces several advanced brain protocols designed to transform addiction treatment. One key component of his approach is Vivitrol®—a monthly, non-habit-forming injection that targets specific opioid receptors in the brain responsible for addictive behaviors. Vivitrol® dramatically reduces cravings for both opioids and alcohol.

According to Dr. Surasky, Vivitrol works on both opioids and alcohol because "all substances of abuse activate the same neurological circuitry." He adds, "We now know exactly where that circuitry is, allowing us to help people in ways we never thought possible." Even if someone relapses with potent opioids like fentanyl, Vivitrol acts as a shield, preventing the drug from binding to these receptors and stopping overdose.

Although Vivitrol has been available for years, it remains widely unknown and underutilized. Traditionally, doctors required patients to stop using opioids for 7 to 10 days before starting Vivitrol, during which time withdrawal is often horrendous, causing shaking, insomnia, restless legs, profuse sweating, panic attacks, and diffuse pain. "It's torturous," Dr. Surasky explains, "which is why many patients opt for Suboxone® or methadone, which don't require a waiting period but perpetuate opioid dependence."

Dr. Surasky's advanced protocol eliminates this need. Using neurological medications, he can shut down withdrawal symptoms entirely, allowing patients to start life-saving Vivitrol® much faster and more comfortably.

Dr. Surasky is also part of a pioneering team exploring high-frequency ultrasound to target and disrupt the brain circuitry that perpetuates addiction. Originally approved by the FDA for treating Parkinson's tremors, this non-invasive technique has the potential to revolutionize addiction treatment. Dr. Surasky and his colleagues at one of N.Y.'s largest hospital systems are actively developing this breakthrough technology.

This work is deeply personal for Dr. Surasky. In his book, he writes: "I watched my only brother, Travis, suffer and ultimately die from this horrible and preventable plague." This loss drives his passion for advancing addiction treatment and saving lives.

Dr. Surasky has been a controversial figure in the medical community. During the COVID-19 pandemic, he frequently appeared on television news shows warning against lockdowns, citing their devastating impact on mental health and addiction, and opposed blanket COVID vaccine mandates, especially for young, healthy individuals.

This Book Will Save Your Life: The New Medical Cure for Opioid Addiction will be available on December 10th, with proceeds supporting charitable initiatives for addiction recovery.

Eden Laikin

Past Chair, Nassau County Prescription Drug Abuse Task Force

Co-Chair, Nassau County Heroin Prevention Task Force

Former Newsday Reporter

Media Contact

Eden Laikin, Neurology News, 1 4067524885, [email protected], Neurology-News.com

SOURCE Neurology News

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.